TECOGEN INC.

TGEN
About the company

Tecogen Inc., together with its subsidiaries, designs, manufactures, markets, and maintains cogeneration products for multi-family residential, commercial, recreational, and industrial use in the United States. It operates in three segments: Products, Services, and Energy Production.

Country: United StatesPrice: $1.91Market Cap: $57.7M

Investment snapshot

0%positive consensus
Scored 1d ago

Positive

0

BUY / PASS

Neutral / negative

1 / 15

NEUTRAL / FAIL

Median fair value

$2.73

+42.9% vs price

Models with upside

1 / 17

Positive margin of safety

Strongest signal

8 of 12 pass — Graham, Buffett, Lynch +1 more object

Key risk

All 16 investors flag TGEN's profitability

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #2589 (Top 83.6%)FAILFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/AN/A+30.0%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-19

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-19

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-19

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Qualitative assessment

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-19

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Where It Passes

  • Debt & Leverage67% pass✓ 11✗ 4▾

    8 of 12 pass — Graham, Buffett, Lynch +1 more object

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.08, IC: -66.8x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.08
    ✓Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities2.69
    ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0.08
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0.08
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=-66.8x, D/EBITDA=N/A
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.08
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.0756; #1165/4210 (top 27.7%)
    ✓AsnessTop 30% of eligible cross-section

Where It Falls Short

  • Profitability0% pass✗ 35▾

    All 16 investors flag TGEN's profitability

    Positive EPS (10 years)1/16 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)2/16 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-22.2%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)-30.5% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$-7.8M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-60.0%
    ✗Lynch> 15%
    EBIT / Enterprise Value-17.7%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-17.7%, ROC=-93.7%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-22.30%
    ✗PiotroskiROA > 0
    ROA Change YoY-15.31% -> -22.30% (delta: -6.99%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=-26.80%, ROA=-22.30%
    ✗PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY43.6% -> 36.3%
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue-38.8%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-60.0%
    ✗Dreman> 12%
    Margin of SafetyP/B=2.6x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity-38.6% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency2/15 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-39.5%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-60.0%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-17.6% (2023) -> -30.5% (2025)
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 40.6% -> 36.3%, operating margin -17.6% -> -30.5%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-17.09%; #4465/6340 (top 70.4%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+31.83%; #1327/3702 (top 35.8%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity-60.05%; #4316/5226 (top 82.6%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.1168; #3669/5884 (top 62.4%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years1/10 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Valuation0% pass✓ 2✗ 26▾

    No clean pass — all 13 investors flag at least one valuation criterion

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio2.6x
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value-17.7%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-17.7%, ROC=-93.7%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    Price / Book Value per Share2.6x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessOE Yield=-13.6%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=-17.9%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=2.6x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Price vs. Trailing Low110% of trailing low ($1.74)
    ✓Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-17.09%; #4465/6340 (top 70.4%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.2846; #3761/6449 (top 58.3%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share3.12x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change+4.1%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.4383; #2814/5247 (top 53.6%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization-16.68%; #3446/4519 (top 76.3%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-32.98%; #4533/6202 (top 73.1%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Cash Flow0% pass✗ 12▾

    All 10 investors flag TGEN's cash flow

    Free Cash Flow Proxy$-7.8M
    ✗BuffettPositive and growing
    FCF Positive and Growing$-9.6M
    ✗LynchPositive and growing
    Operating Cash Flow$-9.9M
    ✗PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=-26.80%, ROA=-22.30%
    ✗PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    P/E or FCF YieldFCF Yield=-17.9%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive3/15 years FCF positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap-16.9%
    ✗Ackman>= 4%
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency3/15 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$-9.6M
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization-16.68%; #3446/4519 (top 76.3%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Growth0% pass✗ 13▾

    All 8 investors flag TGEN's growth

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: 20.2% vs Rev: -9.2%
    ✗LynchInventory growth < Revenue growth
    EPS Growth Direction
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency2/15 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth0.5%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency1/5 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 40.6% -> 36.3%, operating margin -17.6% -> -30.5%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR-0.9%
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Verdicts0% pass✗ 16▾

    Split decision: 15 FAIL · 1 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (1/9)✗BuffettFAIL (0/9)✗LynchFAIL (1/7)✗GreenblattRank #2589✗PiotroskiFAIL (F-Score 3)✗DremanFAIL (2/11)✗MungerFAIL (1/4)✗PabraiFAIL (0/3)✗AkreFAIL (2/6)✗MarksFAIL (0/5)✗AckmanFAIL (2/9)✗TempletonFAIL (3/8)✗SleepFAIL (1/6)✗AsnessFAIL (Rank #2117/2370 (Top 89.3%))✗NeffFAIL (0/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked)
  • Efficiency38% pass✓ 4✗ 7▾

    5 of 8 flag TGEN's efficiency — Buffett, Greenblatt, Munger +2 more

    Current Ratio2.69
    ✓Graham>= 2.0
    ROIC (3-5 yr avg)-34.5%
    ✗Buffett> 10%
    ROIC - WACC-44.5%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)-93.7%
    ✗Greenblatt> 25%
    Current Ratio Change YoY1.32 -> 3.12
    ✓PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.73x -> 0.73x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities2.69
    ✓Dreman> 1.5
    Return on Invested Capital-44.7%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=-23.3%; FY2024: ROIC=-33.7%; FY2025: ROIC=-28.4%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROICN/A (non-positive net income)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest -28.4%)
    ✗SleepROIC > 12% in a majority of years

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Machinery
SIC Sector: Industrial Machinery & Computing
Size: Micro Cap($57.7M)
Revenue: $27.1M+19.7% YoY
Net Income: $8.2M-73.3% YoY

Financial Snapshot

Operating Margin-30.5%
Return on Equity-38.1%
Debt / Equity0.06
Current Ratio3.12
EPS (Diluted)$-0.30
Shares Retired−19.5% / −20.1% 2y

Similar Companies

LRCXLAM RESEARCH CORP
$282.2B
CATCATERPILLAR INC
$274.6B
DEDEERE & CO
$181.6B
JCIJohnson Controls International plc
$84.4B

Shareholder Return

Fiscal 2025

Issued 19.5% of shares last year, 20.1% issued over two.

Buybacks
—
Dividends
—

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-03-19
FY 2024
Sources
  • 10-K · 2025-03-18
FY 2023
Sources
  • 10-K · 2024-03-25
FY 2022
Sources
  • 10-K · 2023-03-23
FY 2021
Sources
  • 10-K · 2022-03-10
Market Cap$57.7Mcurrent------$111.7Mest.$60.2Mest.$18.1Mest.$30.6Mest.$29.1Mest.
Revenue$25.3M↓9%$7.9M↑10%$5.7M↓21%$6.3M↓13%$27.1M↑20%$22.6M↓10%$25.1M↑1%$25.0M↑2%$24.4M
Operating Income-$10.0M↓91%-$1.6M↑25%-$2.2M↓52%-$2.1M↓259%-$8.2M↓82%-$4.5M↓3%-$4.4M↓88%-$2.3M↓93%-$1.2M
Net Income-$9.9M↓81%-$1.6M↑25%-$2.1M↓47%-$2.1M↓221%-$8.2M↓73%-$4.8M↓4%-$4.6M↓88%-$2.4M↓166%$3.7M
EPS (Diluted)--$-0.05↑29%$-0.07↓17%$-0.07↓133%$-0.30↓58%$-0.19$-0.19↓90%$-0.10↓167%$0.15
Gross Margin38.2%37.4%↑23%37.8%↑12%40.9%↓8%36.3%↓17%43.6%↑8%40.6%↓8%44.3%↓7%47.5%
Operating Margin-39.5%↓110%-19.9%↑32%-37.4%↓93%-33.7%↓313%-30.5%↓52%-20.0%↓14%-17.6%↓87%-9.4%↓88%-5.0%
ROE-60.0%↓181%———-38.1%↑18%-46.5%↓49%-31.2%↓143%-12.8%↓174%17.4%
Total Debt$1.2M↑5%$1.2M↑5%$1.3M↑56%$1.4M↑151%$1.3M↑210%$410.9K↑105%$200.2K$0$0
Shareholders' Equity$16.4M↓36%$16.4M↓36%$17.7M↑95%$19.7M↑104%$21.6M↑112%$10.2M↓31%$14.7M↓23%$19.1M↓10%$21.2M
Current Ratio2.69↓1%2.69↓1%2.93↑115%3.02↑119%3.12↑137%1.32↓32%1.94↓32%2.87↑1%2.84
Debt / Equity0.08↑62%0.08↑62%0.07↓20%0.07↑23%0.06↑46%0.04↑196%0.010.000.00
Operating Cash Flow-$9.4M↓198%-$1.4M↑61%-$2.4M↑10%-$3.1M↓165%-$9.9M↓344%$4.1M↑597%-$817.8K↑40%-$1.4M↓391%$465.0K
Free Cash Flow-$9.6M↓164%-$1.4M↑61%-$2.4M↑12%-$3.2M↓142%-$10.3M↓434%$3.1M↑458%-$864.7K↑48%-$1.7M↓546%$373.6K

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Machinery

TGEN vs Peers — Financial Grading

Revenue$27.1MBottom 25%
Net Income$8.2MBottom 25%
ROE-38.1%Bottom 25%
D/E0.06Top 25%
Op. Margin-30.5%Bottom 25%
Curr. Ratio3.12Top 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
LAM RESEARCH CORPLRCX$282.2B$225.92$23.2B$7.3B58.3%0.3035.3%2.633/95/95/71/3F-Score 85/11
CATERPILLAR INCCAT$274.6B$600.20$67.6B$8.9B41.7%1.7016.5%1.442/95/94/71/3F-Score 65/11
DEERE & CODE$181.6B$673.54$45.7B$5.0B19.4%0.5313.7%—2/96/94/70/3F-Score 54/11
Johnson Controls International plcJCI$84.4B$139.33$23.6B$3.3B25.5%0.71—0.932/91/94/71/3F-Score 64/11
CUMMINS INCCMI$61.9B$452.18$33.7B$3.0B23.9%0.5612.0%1.762/94/93/71/3F-Score 67/11
ITT INC.ITT$18.8B$211.18$3.9B$488.0M11.9%0.1917.4%2.582/94/93/71/3F-Score 53/11
REGAL REXNORD CORPRRX$11.7B$176.41$5.9B$279.5M4.1%0.7011.5%2.153/91/91/71/3F-Score 63/11
GRACO INCGGG$11.6B$72.42$2.2B$521.8M19.7%0.0027.9%3.154/97/94/71/3F-Score 75/11